The Novel Use Of Vabysmo (Faricimab), A New Anti-Vegf Agent In The Treatment Of New Corneal Neovascularization.

Published 2023 - 41st Congress of the ESCRS

Reference: PP06.14 | DOI: 10.82333/fjmb-we21